Pharma

Your Article Summary

See Latest Articles

Genentech to Present Advances With Targeted Cancer Medicines at ASCO
Genentech, 05/15/09

Genentech, Inc. provided an overview of results from studies involving the Genentech and Roche combined oncology portfolio that further the companies' approach to developing targeted medicines for people with cancer, a diagnosis that will affect nearly half of Americans during their lifetime. Results from studies involving Genentech's approved and investigational treatments will be presented during the 45th Annual Meeting of the American Society of Clinical Oncology taking place May through June in Orlando, Fla.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

KLAS Ranks PACS Products
HealthDataManagement, 12/11/09

Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas Wednesday, December 9
Repligen, 12/09/09

Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant
Allos Therapeutics, 12/08/09

 See all of Conferences/Meetings

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09

Recombinant Human Erythropoietin, Epogin Injection Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09

Synthon announces European approvals for Raloxifene
Synthon, 12/08/09

 See all of Drug/Product Approvals